These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 9816052)
1. Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1. Foster BJ; Wiegand RA; LoRusso PM; Baker LH Clin Cancer Res; 1995 Aug; 1(8):831-7. PubMed ID: 9816052 [TBL] [Abstract][Full Text] [Related]
2. Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934). LoRusso P; Foster BJ; Poplin E; McCormick J; Kraut M; Flaherty L; Heilbrun LK; Valdivieso M; Baker L Clin Cancer Res; 1995 Dec; 1(12):1487-93. PubMed ID: 9815948 [TBL] [Abstract][Full Text] [Related]
3. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity. Foster BJ; Wiegand RA; Pugh S; LoRusso PM; Rake J; Corbett TH Clin Cancer Res; 1997 Nov; 3(11):2047-53. PubMed ID: 9815596 [TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
7. Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors. Supko JG; Balcerzak SP; Kraut EH Cancer Res; 1993 Oct; 53(20):4843-9. PubMed ID: 8402671 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of pyrazoloacridine in the rhesus monkey. Berg SL; Balis FM; McCully CL; Godwin KS; Poplack DG Cancer Res; 1991 Oct; 51(20):5467-70. PubMed ID: 1913666 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287 [TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730 [TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
14. A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients. Grem JL; Harold N; Keith B; Chen AP; Kao V; Takimoto CH; Hamilton JM; Pang J; Pace M; Jasser GB; Quinn MG; Monahan BP Clin Cancer Res; 2002 Jul; 8(7):2149-56. PubMed ID: 12114415 [TBL] [Abstract][Full Text] [Related]
15. Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers. Berg SL; Blaney SM; Adamson PC; O'Brien M; Poplack DG; Arndt C; Blatt J; Balis FM J Clin Oncol; 1998 Jan; 16(1):181-6. PubMed ID: 9440741 [TBL] [Abstract][Full Text] [Related]
16. Phase I and pharmacokinetic study of a new antineoplastic agent: pyrazine diazohydroxide (NSC 361456). Vogelzang NJ; Mick R; Janisch L; Berezin F; Schilsky RL; Ratain MJ Cancer Res; 1994 Jan; 54(1):114-9. PubMed ID: 8261430 [TBL] [Abstract][Full Text] [Related]
17. Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole. Hantel A; Donehower RC; Rowinsky EK; Vance E; Clarke BV; McGuire WP; Ettinger DS; Noe DA; Grochow LB Cancer Res; 1990 Jun; 50(11):3284-8. PubMed ID: 2334921 [TBL] [Abstract][Full Text] [Related]
18. Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors. Supko JG; Eder JP; Ryan DP; Seiden MV; Lynch TJ; Amrein PC; Kufe DW; Clark JW Clin Cancer Res; 2003 Nov; 9(14):5178-86. PubMed ID: 14613997 [TBL] [Abstract][Full Text] [Related]
19. Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors. Pitot HC; McElroy EA; Reid JM; Windebank AJ; Sloan JA; Erlichman C; Bagniewski PG; Walker DL; Rubin J; Goldberg RM; Adjei AA; Ames MM Clin Cancer Res; 1999 Mar; 5(3):525-31. PubMed ID: 10100703 [TBL] [Abstract][Full Text] [Related]
20. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice. Chan PC Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]